Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-24 2:34 pm Purchase |
2024-12-19 | 13D | Aadi Bioscience, Inc. AADI |
ACUTA CAPITAL PARTNERS LLC | 1,921,297 7.800% |
373,216 (+24.11%) |
Filing History |
| 2023-02-14 3:32 pm Sale |
2022-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-391,209 (Position Closed) |
Filing History |
| 2023-02-14 3:29 pm Sale |
2022-12-31 | 13G | Jiya Acquisition Corp. JYAC |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-562,500 (Position Closed) |
Filing History |
| 2023-02-14 3:26 pm Sale |
2022-12-31 | 13G | BCLS Acquisition Corp. BLSA |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-843,122 (Position Closed) |
Filing History |
| 2022-02-15 2:51 pm Sale |
2021-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 391,209 5.900% |
-24,290 (-5.85%) |
Filing History |
| 2022-02-15 2:48 pm Purchase |
2021-12-31 | 13G | BCLS Acquisition Corp. BLSA |
ACUTA CAPITAL PARTNERS LLC | 843,122 5.700% |
843,122 (New Position) |
Filing History |
| 2022-02-15 2:43 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-863,100 (Position Closed) |
Filing History |
| 2022-02-14 4:39 pm Sale |
2021-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-344,172 (Position Closed) |
Filing History |
| 2021-09-07 5:25 pm Purchase |
2021-08-26 | 13D | Aadi Bioscience, Inc. AADI |
ACUTA CAPITAL PARTNERS LLC | 1,548,081 7.300% |
1,548,081 (New Position) |
Filing History |
| 2021-03-22 06:06 am Purchase |
2021-03-12 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 415,499 8.400% |
165,499 (+66.20%) |
Filing History |
| 2021-02-16 06:14 am Purchase |
2020-12-31 | 13G | Catalyst Biosciences, Inc. CBIO |
ACUTA CAPITAL PARTNERS LLC | 344,172 6.100% |
344,172 (New Position) |
Filing History |
| 2021-02-16 06:14 am Purchase |
2020-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN |
ACUTA CAPITAL PARTNERS LLC | 250,000 5.400% |
250,000 (New Position) |
Filing History |
| 2021-02-16 06:11 am Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% |
863,100 (New Position) |
Filing History |
| 2021-02-16 06:11 am Purchase |
2020-12-31 | 13G | Jiya Acquisition Corp. JYAC |
ACUTA CAPITAL PARTNERS LLC | 562,500 5.200% |
562,500 (New Position) |
Filing History |